Ashley Adams, PA
Medical · Billings, MTNPI 1982258190
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,273 of the $3,553 with a category attached, or 64.0%. 25 manufacturers reported payments, led by Livanova USA, Inc. at 43.4% of the total. Reporting peaked in 2021 at $1,542 and has fallen 74.1% since, to $399 in 2025. Among medical clinicians in MT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 106 payments — averaging $33.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Livanova USA, Inc.$2K
- AbbVie$416
- UCB, Inc.$174
- Argenx US, Inc.$160
- SK Life Science, Inc.$155
- Ironshore Pharmaceuticals Inc.$116
- plus $991 from 19 others
What the payments were for
- Travel & lodging$1,28036%
- Food & beverage$2,27364%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Livanova USA, Inc. | 5 | $1,542 |
| AbbVie | 28 | $416 |
| UCB, Inc. | 6 | $174 |
| Argenx US, Inc. | 7 | $160 |
| SK Life Science, Inc. | 6 | $155 |
| Ironshore Pharmaceuticals Inc. | 9 | $116 |
| Pfizer | 6 | $116 |
| Lilly USA, LLC | 5 | $94 |
| AstraZeneca | 3 | $82 |
| Otsuka America Pharmaceutical, Inc. | 3 | $69 |
| Eisai Inc. | 3 | $66 |
| GSK | 2 | $59 |
| Novartis | 2 | $57 |
| Genentech USA, Inc. | 3 | $52 |
| ANI Pharmaceuticals, Inc. | 2 | $52 |
| Merz Pharmaceuticals, LLC | 3 | $50 |
| Medtronic | 1 | $47 |
| CSL Behring | 2 | $44 |
| Johnson & Johnson | 2 | $40 |
| TG Therapeutics, Inc. | 2 | $39 |
| Amgen | 2 | $38 |
| Boston Scientific | 1 | $31 |
| Amneal Pharmaceuticals LLC | 1 | $21 |
| Kyowa Kirin, Inc. | 1 | $16 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VNS - Sentiva$1,542
How this compares
$3,553 in reported general payments places this provider in the 90th percentile of 134 medical providers in Montana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nurtec OdtRimegepant Sulfate | 30 | $30,498 |
| Emgality PenGalcanezumab-Gnlm | 27 | $18,272 |
| Aimovig AutoinjectorErenumab-Aooe | 14 | $15,224 |
| Sumatriptan Succinate | 65 | $13,326 |
| Rasagiline Mesylate | 13 | $5,872 |
| Gabapentin | 133 | $3,064 |
| Levetiracetam | 62 | $2,569 |
| Eletriptan HbrEletriptan Hydrobromide | 14 | $2,540 |
| Duloxetine Hcl | 86 | $2,481 |
| Baclofen | 33 | $2,268 |
| Pregabalin | 46 | $2,101 |
| Memantine Hcl | 35 | $1,641 |
| Amitriptyline Hcl | 55 | $1,220 |
| Levetiracetam ErLevetiracetam | 11 | $1,132 |
| Carbidopa-Levodopa ErCarbidopa/Levodopa | 12 | $973 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerNurtec Odt | $116 | $30,49830 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 134 medical providers in Montana.
Other medical in Billings
- Erin LafavorBillings$6K
- Gabriel BlomquistBillings$5K
- Michael HinesBillings$5K
- Hans BoneBillings$3K
- Kristen KaferBillings$866
- Katherine GoynBillings$832
- Aimee Alvord BrownBillings$807
- Emma JacksonBillings$793
- Taylor PohleBillings$604
- Kellsie QuinnBillings$382
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.